Eli Lilly anchors Zacks' latest Analyst Blog, with new research highlighting pharma growth drivers alongside global energy and banking insights.

LLY's strong GLP-1 demand, international launches and new drug contributions highlight why it leads today's top analyst reports lineup.

The government clarified that shell companies are not defined in company law, but inactive entities are removed through statutory strike-off provisions. The key takeaway is that enforcement relies on ...

Cisco confirms an unpatched CVSS 10.0 zero-day in AsyncOS actively exploited to gain root access on email security appliances ...

Low-Earth orbit (LEO) systems have emerged as a promising complement to GNSS, offering higher received power, better ...

Kentucky Fresh Harvest has spent 10 years refining its indoor farming model and the last two years convincing investors they ...

Precise positioning is increasingly critical for applications ranging from autonomous mobility to resilient infrastructure ...

Critical React Server Components flaw (CVE-2025-55182) fuels automated attacks dropping miners and multiple new Linux malware ...

While flash drives are more portable, they can't match the speeds of bulkier SSDs. However, Kingston's Dual Portable SSD ...

Ransomware groups are targeting hypervisors to maximize impact, allowing a single breach to encrypt dozens of virtual ...

The luxury travel brand's new three-in-one travel accessory offers genuine utility for hard-shell suitcase devotees, provided ...

Reuters.com is your online source for the latest Mexico news stories and current events, ensuring our readers up to date with ...